Riding on Novo Nordisk's semaglutide, India's weight-loss market triples in size in 2 years

Semgalutide has almost 66 percent of the market share in the anti-obesity segment.

Related Keywords

Manipal ,Karnataka ,India ,Denmark ,Danish ,Sun Pharma ,Sheetal Sapale ,Eli Lilly ,Central Drug Authority ,Dr Reddy Labs ,Cipla ,Novo Nordisk ,Biocon ,Moving Annual Total ,Alembic Pharma ,Semaglutide ,Ozempic ,Abbott ,Weight Loss Drug ,